中国组织工程研究 ›› 2018, Vol. 22 ›› Issue (34): 5433-5438.doi: 10.3969/j.issn.2095-4344.0637

• 组织工程骨及软骨材料 tissue-engineered bone and cartilage materials • 上一篇    下一篇

聚对苯二甲酸乙二醇酯囊袋加压椎体后凸成形治疗Kummell病

李志君,慈 元,郑玉鹏,张光宇   

  1. 大连市第二人民医院脊柱外科,辽宁省大连市 116011
  • 收稿日期:2018-06-26 出版日期:2018-12-08 发布日期:2018-12-08
  • 通讯作者: 李志君,副主任医师,大连市第二人民医院脊柱外科,辽宁省大连市 116011
  • 作者简介:李志君,男,1979年生,黑龙江省哈尔滨市人,汉族,2008年大连医科大学毕业,硕士,副主任医师,主要从事脊柱外科研究。

Kyphoplasty with polyethylene terephthalate treats Kummell disease

Li Zhijun, Ci Yuan, Zheng Yupeng, Zhang Guangyu   

  1. Department of Spinal Surgery, Second People’s Hospital of Dalian, Dalian 116011, Liaoning Province, China
  • Received:2018-06-26 Online:2018-12-08 Published:2018-12-08
  • Contact: Li Zhijun, Department of Spinal Surgery, Second People’s Hospital of Dalian, Dalian 116011, Liaoning Province, China)
  • About author:Li Zhijun, Master, Associate chief physician, Department of Spinal Surgery, Second People’s Hospital of Dalian, Dalian 116011, Liaoning Province, China

摘要:

文章快速阅读:

 

文题释义:
聚对苯二甲酸乙二酯囊袋加压椎体成形:作为经皮椎体成形和经皮椎体后凸成形的改良和发展,利用工作通道将骨填充囊袋置入椎体内,将骨水泥直接加压注入囊袋内,在囊袋膨胀复位的同时,完成骨水泥的注射,既可避免了椎体后凸成形球囊撤出后的再塌陷,又应用聚对苯二甲酸乙二酯囊袋限制了骨水泥的弥散,减少骨水泥的渗漏率。
Kummell病:是一种特殊类型的骨质疏松性椎体骨折不愈合,亦被称为创伤后迟发性椎体骨坏死、迟发性椎体塌陷、椎体假关节及椎体压缩性骨折不愈合等,是继发于中老年骨质疏松性椎体骨折之后的特殊疾病,其病理机制、病因发生不明确,发生率可占骨质疏松性椎体骨折患者的7%-24%。
 
 
背景:聚对苯二甲酸乙二酯囊袋加压椎体成形治疗骨质疏松性椎体压缩骨折可快速疼痛缓解,恢复椎体高度及矫正后凸畸形,而关于其治疗Kummell病的报道不多。
目的:评估聚对苯二甲酸乙二酯囊袋加压椎体后凸成形治疗Kummell病的疗效及安全性。
方法:纳入17例老年Kummell病患者,其中男5例,女12例,年龄67-72岁,涉及T11椎体2个、T12椎体7个、L1椎体5个、L2椎体2个、L3椎体1个。17例患者均进行聚对苯二甲酸乙二酯囊袋加压椎体后凸成形治疗,治疗前后进行疼痛、生活能力及影像学评估。

结果与结论:①疼痛缓解:17例患者治疗后3 d、3个月、6个月的目测类比评分均明显低于治疗前(P < 0.05);②生活能力:17例患者治疗后3 d、3个月、6个月的平均Oswestry功能障碍指数评分均明显低于治疗前     (P < 0.05);③影像学评估:17例患者治疗后3 d、3个月、6个月的伤椎椎体前缘高度及椎体中线高度均明显高于治疗前(P < 0.05),Cobb 角明显低于治疗前(P < 0.05);④不良反应:未发生椎管内及血管内骨水泥渗漏,未发生与骨水泥材料相关的不良反应;⑤结果表明:聚对苯二甲酸乙二酯囊袋加压椎体成形治疗老年Kummell病可快速缓解疼痛,重建脊柱稳定性,改善患者生活质量且安全性较高。

ORCID: 0000-0002-2634-3453(李志君)

中国组织工程研究杂志出版内容重点:生物材料;骨生物材料; 口腔生物材料; 纳米材料; 缓释材料; 材料相容性;组织工程

关键词: 骨生物材料, Kummell病, 骨质疏松, 囊袋加压椎体成形术, 聚对苯二甲酸乙二酯, 椎体内真空裂隙, 骨水泥, 目测类比评分, Oswestry功能障碍指数, 生物材料

Abstract:

BACKGROUND: Kyphoplasty with polyethylene terephthalate can relieve pain quickly, restore the vertebral height and correct kyphosis. However, there are less reports on percutaneous kyphoplasty to deal with the Kummell's disease.

OBJECTIVE: To evaluate the efficacy and safety of percutaneous kyphoplasty with polyethylene terephthalate in treating Kummell disease.
METHODS: Seventeen patients with Kummell disease (5 males and 12 females) aged 67 to 72 years old were included in this study. Affected vertebral segments included T11 in two cases, T12 in seven cases, L1 in five cases, L2 in two cases, and L3 in one case. All the patients were treated by percutaneous kyphoplasty with polyethylene terephthalate. Pain relief, living ability and imaging evaluations were performed before and after the surgery.
RESULTS AND CONCLUSION: (1) Pain relief: The Visual Analogue Scale scores in the 17 patients were significantly lowered at 3 days, 3 months and 6 months after the surgery than the preoperative scores (P < 0.05). (2) Living ability: The mean Oswestry disability index scores in 17 patients at 3 days, 3 months and 6 months after the surgery were lowered compared to the preoperative scores (P < 0.05). (3) Imaging evaluation: The height of the anterior and middle line vertebral body in 17 patients at 3 days, 3 months and 6 months after the surgery were higher than the preoperative (P < 0.05), and the Cobb angle was significantly lowered compared to the preoperative (P < 0.05). (4) Adverse reaction: There was no leakage of bone cement in the vertebral canal and vessels, and no adverse reactions related to bone cement occurred. These results suggest that the percutaneous kyphoplasty with polyethylene terephthalate is safe in treating elderly Kummell disease, which can relieve pain quickly, improve patients’ quality of life, and rebuild the spinal stability. 

Key words: Kyphoplasty, Osteoporosis, Tissue Engineering

中图分类号: